Back
Aardvark Therapeutics, Inc. 10K Form
Sell
37
AARD
Aardvark Therapeutics, Inc.
Last Price:
$13.25
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AARD News And Ratings
See the #1 stock for the next 7 days that we like better than AARD
AARD Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-18.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.63 |
| Price / Book: | 2.35 |
Profitability
| EPS (TTM): | -2.24650 |
|---|---|
| Net Income (TTM): | $-48.8M |
| Gross Margin: | $-16K |
| Return on Equity: | -43.34% |
| Return on Assets: | -40.71% |
Aardvark Therapeutics, Inc. Earnings Forecast
Key Aardvark Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 3 years have been positive in 1 years.
Aardvark Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | AARD |
| Website: | aardvarktherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 12.03 |
| Quick Ratio: | 11.77 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AARD Technical Analysis vs Fundamental Analysis
Sell
37
Aardvark Therapeutics, Inc. (AARD)
is a Sell
Is Aardvark Therapeutics, Inc. a Buy or a Sell?
-
Aardvark Therapeutics, Inc. stock is rated a SellThe current Aardvark Therapeutics, Inc. [AARD] share price is $13.23. The Score for AARD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.